NO20073256L - Vaksiner mot meningococcus - Google Patents
Vaksiner mot meningococcusInfo
- Publication number
- NO20073256L NO20073256L NO20073256A NO20073256A NO20073256L NO 20073256 L NO20073256 L NO 20073256L NO 20073256 A NO20073256 A NO 20073256A NO 20073256 A NO20073256 A NO 20073256A NO 20073256 L NO20073256 L NO 20073256L
- Authority
- NO
- Norway
- Prior art keywords
- fragment
- variant
- vaccines against
- against meningococcus
- polypeptide
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det er beskrevet ulike polypeptider, eller en variant eller fragment av det, eller en fusjon av disse, som er nyttige i en vaksine. Polypeptidet kan være et polypeptid omfattende aminosyre-sekvensen valgt fra en av SEQ ID Nos 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68; eller et fragment eller variant av det, eller en fusjon av et slikt fragment eller variant, og er nyttig i en vaksine mot Neisseria meningitidis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2004/005441 WO2005060995A2 (en) | 2003-12-23 | 2004-12-23 | Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| PCT/GB2005/005113 WO2006067518A2 (en) | 2004-12-23 | 2005-12-23 | Vaccines against neisseria meningitidis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073256L true NO20073256L (no) | 2007-09-17 |
Family
ID=36282716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073256A NO20073256L (no) | 2004-12-23 | 2007-06-25 | Vaksiner mot meningococcus |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1848457A2 (no) |
| JP (1) | JP2008525008A (no) |
| KR (1) | KR20070094762A (no) |
| CN (2) | CN101115502A (no) |
| AU (1) | AU2005317835A1 (no) |
| CA (1) | CA2592156A1 (no) |
| MX (1) | MX2007007886A (no) |
| NO (1) | NO20073256L (no) |
| RU (1) | RU2007127921A (no) |
| WO (1) | WO2006067518A2 (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007072032A2 (en) * | 2005-12-23 | 2007-06-28 | Imperial Innovations Limited | Neisseria meningitidis vaccines and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9814902D0 (en) * | 1998-07-10 | 1998-09-09 | Univ Nottingham | Screening of neisserial vaccine candidates against pathogenic neisseria |
-
2005
- 2005-12-23 KR KR1020077015481A patent/KR20070094762A/ko not_active Application Discontinuation
- 2005-12-23 MX MX2007007886A patent/MX2007007886A/es unknown
- 2005-12-23 CA CA002592156A patent/CA2592156A1/en not_active Abandoned
- 2005-12-23 WO PCT/GB2005/005113 patent/WO2006067518A2/en active Application Filing
- 2005-12-23 RU RU2007127921/13A patent/RU2007127921A/ru not_active Application Discontinuation
- 2005-12-23 JP JP2007547670A patent/JP2008525008A/ja active Pending
- 2005-12-23 AU AU2005317835A patent/AU2005317835A1/en not_active Abandoned
- 2005-12-23 CN CNA2005800479621A patent/CN101115502A/zh active Pending
- 2005-12-23 EP EP05823115A patent/EP1848457A2/en not_active Withdrawn
-
2006
- 2006-12-21 CN CNA2006800516894A patent/CN101370514A/zh active Pending
-
2007
- 2007-06-25 NO NO20073256A patent/NO20073256L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005317835A1 (en) | 2006-06-29 |
| JP2008525008A (ja) | 2008-07-17 |
| WO2006067518A2 (en) | 2006-06-29 |
| RU2007127921A (ru) | 2009-01-27 |
| MX2007007886A (es) | 2008-01-16 |
| KR20070094762A (ko) | 2007-09-21 |
| EP1848457A2 (en) | 2007-10-31 |
| CN101370514A (zh) | 2009-02-18 |
| CN101115502A (zh) | 2008-01-30 |
| WO2006067518A3 (en) | 2006-11-23 |
| CA2592156A1 (en) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063026L (no) | Antistoffer | |
| DK1194560T3 (da) | Antigene Neisseria-peptider | |
| GB2439474A (en) | LI-Key/Antigenic epitope hybrid peptide vaccines | |
| DK1093517T3 (da) | Neisseria-meningitidis-antigener og præparater | |
| ATE397068T1 (de) | Antigene meningokokken peptide | |
| NO20050008L (no) | Neisserial vaksinesammensetninger omfattende en kombinasjon av antigener | |
| EP2289545A3 (en) | Supplemented OMV vaccine against meningococcus | |
| DK1904529T3 (da) | Anvendelse af Stefin A som et scaffoldprotein | |
| ATE476508T1 (de) | Neisseriale antigene | |
| ATE468127T1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| UA107330C2 (uk) | Туберкульозний білок rv3616c та його застосування | |
| WO2009025117A1 (ja) | Cdca1ペプチド及びこれを含む薬剤 | |
| DK1328547T3 (da) | Identifikation og modifikation af immundominante epitoper i polypeptider | |
| DE602004025943D1 (de) | Mikrosomvakzin | |
| ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
| ATE457352T1 (de) | Subtilisin-carlsberg-proteine mit verminderter immunogenität | |
| EP1932915A3 (en) | Materials and methods relating to improved vaccination strategies | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| DK1214088T3 (da) | Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner | |
| NO20073256L (no) | Vaksiner mot meningococcus | |
| ATE466876T1 (de) | Immunogene konstrukte | |
| ATE474589T1 (de) | Angiogene peptide und ihre verwendungen | |
| MY144766A (en) | Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof | |
| NO20082810L (no) | Vaksine, og anvendelse av samme | |
| NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |